Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population

Neurological Research

Volumn 28, Issue 5, 2006, Pages 549-554

  Huang, Qing ^a   Liu, Yun Hai ^a   Yang, Qi Dong ^a   Xiao, Bo ^a   Ge, Liang ^b   Zhang, Ning ^a   Xia, Jian ^a   Zhang, Le ^a   Liu, Zun Jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b People's Hospital of Hunan Province   (China)

Author keywords

Atherosclerosis; Cerebral infarction; Genotype; Human serum paraoxonase; Polymorphism

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE; GLUTAMINE; ISOLEUCINE; METHIONINE; RESTRICTION ENDONUCLEASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN SERUM PARAOXONASE GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PON1 GENE; POPULATION GENETICS; RESTRICTION MAPPING; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBRAL INFARCTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33746511459     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X110337     Document Type: Article

References (30)

1. Ayala C, Croft JB, Greenland KJ, et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002; 33: 1197-1201
2. Davies HG, Richter RJ, Keifer M, et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996; 14: 334-336
3. Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581-1590
4. Mackness MI, Arrol S, Abbott C, et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-135
5. Ombres D, Pannitteri G, Montali A, et al. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 1998; 18: 1611-1616
6. Blatter MC, James RW, Messmer S, et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993; 211: 871-879
7. Kelso GJ, Stuart WD, Richter RJ, et al. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry 1994; 33: 832-839
8. Ruiz J, Blanche H, James RW, et al. Gln-Argl 92 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869-872
9. Serrato M, Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995; 96: 3005-3008
10. Odawara M, Tachi Y, Yamashita K. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary artery disease in Japanese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 2257-2260
11. Sanghera DK, Saha N, Aston CE, et al. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997; 17: 1063-1073
12. Antikainen M, Murtomaki S, Syvanne M, et al. The Gln-Arg 191 polymorphism of human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest 1996; 98: 883-885
13. Herrmann SM, Blanc H, Poirier O, et al. The Gin/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study. Atherosclerosis 1996; 126: 299-303
14. Area M, Ombres D, Montali A, et al. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population. Eur J Clin Invest 2002; 32: 9-15
15. Garin MC, James RW, Dussoix P, et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997; 99: 62-66
16. Gardemann A, Philipp M, Hess K, et al. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis 2000; 152: 421-431
17. Zama T, Murata M, Matsubara Y, et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 1997; 17: 3565-3569
18. Ko YL, Ko YS, Wang SM, et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 1998; 141: 259-264
19. Wang X, Fan Z, Huang J, et al. Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 2003; 23: 328-334
20. Schmidt H, Schmidt R, Niederkorn K, et al. Paraoxonase PON1 polymorphism Leu-Met54 is associated with carotid atherosclerosis: Results of the Austrian Stroke Prevention Study. Stroke 1998; 29: 2043-2048
21. Malin R, Loimaala A, Nenonen A, et al. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism 2001; 50: 1095-1101
22. Imai Y, Morita H, Kurihara H, et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 2000; 149: 435-442
23. Ueno T, Shimazaki E, Matsumoto T, et al. Paraoxonasel polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit 2003; 9: CR208-212
24. Topic E, Timundic AM, Ttefanovic M, et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001; 39: 346-350
25. Koch M, Hering S, Barth C, et al. Paraoxonase 1 192 Gin/Arg gene polymorphism and cerebrovascular disease: Interaction with type 2 diabetes. Exp Clin Endocrinol Diabetes 2001; 109: 141-145
26. Rea IM, McKeown PP, McMaster D. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 2004; 39: 629-635
27. Lansbury AJ, Catto AJ, Carter AM, et al. The paraoxonase glutamine/arginine polymorphism and cerebrovascular disease. Cerebrovasc Dis 1997; 7: 353-356
28. Schmidt R, Schmidt H, Falzekas F, et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: Three-year follow-up of the Austrian stroke prevention study. Arterioscler Thromb Vasc Biol 2000; 20: 1811-1816
29. Oliveira SA, Mansur AP, Ribeiro CC, et al. PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Cardiol 2004; 94: 73-77
30. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb, and Vasc Biol 1995; 15: 89-95